COVID-19 IgG/IgM Rapid Test

COVID 19 (SARS-CoV-2) IgG/IgM Rapid Lateral Flow Test (colloidal gold based)

OEM only


    Formats: 

    - Uncut Sheets

   

IgM/IgG Rapid Kit can specifically detect IgM and IgG antibodies of COVID-19, covering the entire course of infection and recovery period of patients. This approach improves the overall diagnosis of COVID-19 in both acute and recovery phases of illness.


This kit utilizes the principle of colloidal gold immunochromatography to qualitatively detect the new coronavirus (COVID-19) IgG / IgM antibodies in human serum and plasma. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of COVID-19 suspected patients.

This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well, and then add the required amount of a diluent. The resultat will be availible within 20 min. 


Accuracy:80% ~ 90%

Specificity: 97%


Download the protocol: COVID-19 IgG IgM (SARS-CoV-2) Rapid Lateral Flow Test (colloidal gold-based)




AIVD’s POCT has been tested by the Chinese CDC; commonly utilized in Wuhan recovery centers and isolated areas, hospitals all over China.






IgG

IgM

Result Judgment

-

-

If there are clinical symptoms, such as fever, cough, and lung lesions on CT, then it can be determined as a suspected patient. Recommended test the patient using COVID-19 IgG/IgM test cassette or PCR-based method within the next 7 days one more time.

-

+

If the CT shows a presence of a lung disease, the patient could be considered as a COVID-19 infected patient in the early stage of infection

+

+

Confirmed patient

+

-

Confirmed patients. If there are no clinical symptoms, could be patients, who are getting a medical treatment at the moment or already got a treatment course and need to be observed in following several days, if IgM does not appear positive, and no clinical symptoms reappear, the patient can be determined as a recovered patient.